Paul Tudor Jones II Jade Biosciences, Inc.

2 Paul Tudor Jones II Jade Biosciences Trades

Paul Tudor Jones II started to build up the position in Jade Biosciences in Q4 2025. Since then they sold 24.2k shares. The investor sold all their shares in Q1 2026 and doesn't own any shares in Jade Biosciences anymore.

News about Jade Biosciences, Inc. and Paul Tudor Jones II

Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals

Aerovate's (AVTE) shares plunge 93% as its lead candidate, AV-101, fails to meet the primary and secondary endpoints in the phase IIb/III study to treat pulm...

zacks.com, about 2 years ago